The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volovchenko A.N.

Sechenov First Moscow State Medical University

Syrkina E.A.

The first Moscow State Medical University named after I.M. Sechenov (Sechenov University)

Syrkin A.L.

Sechenov First Moscow State Medical University

Chomakhidze P.Sh.

Sechenov First Moscow State Medical University

Gogniyeva D.G.

The first Moscow State Medical University named after I.M. Sechenov (Sechenov University)

Impact of antiarrhythmic therapy on pacemaker parameters in patients with tachycardia-bradycardia syndrome

Authors:

Volovchenko A.N., Syrkina E.A., Syrkin A.L., Chomakhidze P.Sh., Gogniyeva D.G.

More about the authors

Read: 2578 times


To cite this article:

Volovchenko AN, Syrkina EA, Syrkin AL, Chomakhidze PSh, Gogniyeva DG. Impact of antiarrhythmic therapy on pacemaker parameters in patients with tachycardia-bradycardia syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):622‑626. (In Russ.)
https://doi.org/10.17116/kardio202215061622

Recommended articles:
Left atrial redu­ction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470
Hemo­rrhagic and thro­mboembolic complications in catheter abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):628-633
Correction of postoperative meta­bolic diso­rders after radiofrequency abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):680-684
Pote­ntial for the six-minute walk test use in patients with atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(10):129-133
Popu­lation portrait of the atrial fibrillation by the ESSE-RF study.. Russian Journal of Preventive Medi­cine. 2025;(11):7-13

References:

  1. Zhang YY, Qiu C, Davis PJ et al. Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF) _ United States cohort. Am J Cardiol. 2013;112:79-84. 
  2. Kelly JP, DeVore AD, Wu JJ, et al. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines — Heart Failure. J Am Heart Assoc. 2019;8(24):e011560.
  3. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383:1305-1316. https://doi.org/10.1056/NEJMoa2019422
  4. Eitel C, Husser D, Hindricks G, et al. Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace. 2011;13(4):480-485. 
  5. Buck BH, Hill MD, Quinn FR et al. Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial. JAMA. 2021;325(21):2160-2168. https://doi.org/10.1001/jama.2021.6128
  6. Dan GA, Martinez-Rubio A, Agewall S et al. ESC Scientific Document Group. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace. 2018;20(5):731-732. 
  7. Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070-1180. https://doi.org/10.1093/europace/eut206
  8. Sweeney MO, Hellkamp AS. Heart failure during cardiac pacing. Circulation. 2006;113(17):2082-2088. https://doi.org/10.1161/CIRCULATIONAHA.105.608356
  9. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA. Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932-2937. https://doi.org/10.1161/01.CIR.0000072769.17295.B1
  10. Dan G-A, Martinez-Rubio A, Agewall S, et al. Antiarrhyth mic drugs — clinical use and clinical decision-making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace. 2018;20:731-732.  https://doi.org/10.1093/europace/eux373
  11. Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123(9):1010-1020. https://doi.org/10.1161/CIRCULATIONAHA.110.940577
  12. Clinical recommendations for electrophysiologyical studies, catheter ablation and implantable antiarrhythmic devices. All-Russian Scientific Society of Specialists on Clinical Electrophysiology, Arrhythmology and Pacing. M.: New edition; 2017;141-150. (In Russ.).
  13. Volovchenko AN, Syrkina EA, Syrkin AL, et al. Antiarrhythmic therapy in patients with paroxysmal atrial fibrillation and permanent cardiac pacing. Annals of arrhythmology. 2021;18(3):162-169. (In Russ.). https://doi.org/10.15275/annaritmol.2021.3.5

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.